RxDoctor Payments Data

Robert Anderson

Hematology & Oncology · Waco, TXNPI 1760425706

Payments from drug & device makers

$981,190in general payments, 2019–2025

Across 29 payments — averaging $33,834 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$976K
  • Novartis$5K
  • Boston Scientific$148
  • Clovis Oncology, Inc.$110
  • Pfizer$109
  • Incyte Corporation$108
  • plus $236 from 4 others
$720in research payments, 2019–2025

Across 3 payments — averaging $240.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$720

What the payments were for

  • Food & beverage$60883%
  • Education$12117%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$981,190 in reported general payments places this provider in the 85th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas

Other hematology & oncology in Waco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →